ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP5F1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP5J2 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP7A | ATPase, Cu++ transporting, alpha polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ATP8A1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP9A | ATPase, class II, type 9A | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
B4GALT3 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
BACE1 | Beta-site APP-cleaving enzyme 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BANP | BTG3 associated nuclear protein | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BBS4 | Bardet-Biedl syndrome 4 | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BOC | BOC cell adhesion associated, oncogene regulated | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
BST2 | Bone marrow stromal cell antigen 2 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
BTN2A2 | Butyrophilin, subfamily 2, member A2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C14orf2 | Chromosome 14 open reading frame 2 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
C15orf27 | Chromosome 15 open reading frame 27 | Predicted membrane proteins
| | | | | Tissue enhanced |
C19orf24 | Chromosome 19 open reading frame 24 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
C1orf159 | Chromosome 1 open reading frame 159 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
C2CD5 | C2 calcium-dependent domain containing 5 | Predicted intracellular proteins
| | | | | Expressed in all |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C9orf69 | Chromosome 9 open reading frame 69 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CADM1 | Cell adhesion molecule 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
CAMKMT | Calmodulin-lysine N-methyltransferase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CASC4 | Cancer susceptibility candidate 4 | Predicted intracellular proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CAV3 | Caveolin 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CCDC107 | Coiled-coil domain containing 107 | Predicted membrane proteins
| | | | | Expressed in all |
CCDC112 | Coiled-coil domain containing 112 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CCDC127 | Coiled-coil domain containing 127 | Predicted intracellular proteins
| | | | | Mixed |
CCDC51 | Coiled-coil domain containing 51 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CCDC90B | Coiled-coil domain containing 90B | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD33 | CD33 molecule | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CD4 | CD4 molecule | CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD47 | CD47 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |